![Eric Faulkner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Faulkner
Chief Tech/Sci/R&D Officer at
CNS PHARMACEUTICALS, INC.
Net worth: 13 815 $ as of 31/07/2026
Profile
Eric Faulkner is Chief Technology Officer at CNS Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Faulkner was Chief Technical Officer at IO Biotech, Inc. Education includes an MBA from Boston University and graduate studies at the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/08/2026 | 2,375 ( 0.16% ) | 13 815 $ | 31/07/2026 |
Eric Faulkner active positions
| Companies | Position | Start |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 02/03/2026 |
Former positions of Eric Faulkner
| Companies | Position | End |
|---|---|---|
| IO BIOTECH, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Eric Faulkner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
- Stock Market
- Insiders
- Eric Faulkner
